摘要 |
The invention relates to a pharmaceutical composition in combination with a tube feed intended for artificial feeding in the treatment of digestive disorders in artificial feeding, where the pharmaceutical composition comprises or consists of at least one digestive enzyme, preferably a lipase, more preferably a bacterial lipase, very preferably burlulipase (INN) in fluid administration form, with the pharmaceutical composition and the tube feed being formulated for administration simultaneously but separately from one another. The pharmaceutical composition can therefore be administered simultaneously and continuously during administration of the tube feed, but separately from it. As a result, the digestive performance of a patient being artificially fed can successfully be boosted significantly. |